COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,624 Articles (22,913 medRxiv, 8,711 bioRxiv)

Most recent first Previous |  Page 456: Articles 4551-4560  | Next

Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
Garcia-Bernalt Diego, J., Singh, G., Jangra, S., Handrejk, K., Laporte, M., Chang, L. A., El Zahed, S. S., Pache, L., Chang, M. W., Warang, P., Aslam, S., Mena, I., Webb, B. T., Benner, C., Garcia-Sastre, A., Schotsaert, M.
10.1101/2023.05.22.541294 — Posted: 2023-05-22
The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model: Role of complement in cardiovascular, hematological, and inflammatory mediator changes
Barta, B. A., Radovits, T., Dobos, A. B., Kozma, G. T., Meszaros, T., Berenyi, P., Facsko, R., Fulop, T. G., Merkely, B., Szebeni, J.
10.1101/2023.05.19.541479 — Posted: 2023-05-22
Contrasting the open access dissemination of COVID-19 and SDG research
Lariviere, V., Basson, I., Clack, J.
10.1101/2023.05.18.541286 — Posted: 2023-05-21
Impact of the COVID-19 pandemic on low back pain management in commercially insured and Medicare Advantage cohorts. A retrospective cohort study
Elton, D., Zhang, M.
10.1101/2023.05.15.23289993 — Posted: 2023-05-21
Drug Overdose Mortality Rates by Educational Attainment and Sex for Adults Aged 25 to 64 in the United States Before and During the COVID-19 Pandemic, 2015 to 2021
Xu, J. J., Seamans, M. J., Friedman, J. R.
10.1101/2023.05.19.23290239 — Posted: 2023-05-21
Intentions and Willingness to receive Covid-19 vaccine among teaching and non-teaching staff in selected higher institutions of learning in Kampala and Wakiso districts, Central -Uganda
Lulu, P. M., Atim, F., Kareodu, R., Wakula, F. L., Okiria, J. C.
10.1101/2023.05.16.23290042 — Posted: 2023-05-21
Evaluating the Association of Depressive Disorder Symptoms and Moral Injuries in Healthcare Workers during COVID-19 Pandemic
Behnampour, A., Ebrahimi, S., Bazrafshan, A., Kamyab, A., Pakdin, M., Ebrahimi, A.
10.1101/2023.05.20.23290269 — Posted: 2023-05-21
Defining the Subtypes of Long COVID and Risk Factors for Prolonged Disease
Resendez, S., Brown, S. H., Ruiz, S., Rangan, P., Nebeker, J. K., Montella, D., Elkin, P. L.
10.1101/2023.05.19.23290234 — Posted: 2023-05-21
Viral rebound among patients receiving COVID-19 convalescent plasma for treatment of Covid-19 in Uganda.
Alupo, P., Muttamba, W., Mugenyi, L., Kimuli, I., Katagira, W., Kirenga, B.
10.1101/2023.05.16.23290033 — Posted: 2023-05-21
Predicting the public health impact of bivalent vaccines and nirmatrelvir-ritonavir against COVID-19
Park, H. J., Tan, S. T., Leon, T. M., Jain, S., Schechter, R., Lo, N. C.
10.1101/2023.05.18.23289533 — Posted: 2023-05-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).